It's been 30 years since a new drug to delay kidney disease progression in adults with type 1 diabetes was successful in a clinical trial -- the last being the ACE inhibitor captopril in 1993 -- noted ...

Dublin, March 19, 2021 (GLOBE NEWSWIRE) -- The "Hyperkalemia - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...

Please provide your email address to receive an email when new articles are posted on . Solid organ transplant recipients who develop hyperkalemia have an increased risk of mortality and 30-day ...

Hyperkalemia is a potentially serious condition that can result in life-threatening cardiac arrhythmias and is associated with an increased mortality risk. Patients older than 65 years who have an ...

LISBON, PORTUGAL — Elevated potassium is common and associated with poor outcomes in a real-world population of patients with diabetes, new research finds. Results from the Danish population-based ...

Postoperative hyperkalemia is an important complication of adrenalectomy for aldosterone-producing adenoma. Recently, postoperative hyperkalemia has been found to have a relatively high incidence ...

Although serum potassium monitoring is recommended to reduce the risk of hyperkalemia, only a small percentage of patients taking RAAS inhibitors are monitored. Hyperkalemia diagnosis is often missed ...

Please provide your email address to receive an email when new articles are posted on . The National Kidney Foundation launched a public education video series about hyperkalemia for patients with ...

Hyperkalemia is an abnormally high level of potassium in the blood. The normal level of serum potassium (potassium in the fluid portion of the blood) is 3.5 to 5.0 mmol/l. When serum potassium is ...

G_hyperkalemia_web How much do your patients know about the dangers of high potassium levels in the body? They may know that potassium is good for you, or that you need specific levels of it in the ...

October 8, 2009 (UPDATED October 23, 2009) — Angiotensin-converting enzyme inhibitors (ACEIs) are more likely than other antihypertensive drugs to cause hyperkalemia, according to the results of a ...